Development of a novel plaque reduction neutralisation test for hantavirus infection

<p>In the Americas, hantaviruses cause severe cardiopulmonary syndrome (HCPS) with a high fatality rate. Hantavirus infection is commonly diagnosed using serologic techniques and reverse transcription-polymerase chain reaction. This paper presents a novel plaque reduction neutralisation test (...

Full description

Bibliographic Details
Main Authors: Michelly de Pádua, William Marciel de Souza, Flávio Lauretti, Luiz Tadeu Moraes Figueiredo
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2015-08-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762015000500624&lng=en&tlng=en
_version_ 1797757295517499392
author Michelly de Pádua
William Marciel de Souza
Flávio Lauretti
Luiz Tadeu Moraes Figueiredo
author_facet Michelly de Pádua
William Marciel de Souza
Flávio Lauretti
Luiz Tadeu Moraes Figueiredo
author_sort Michelly de Pádua
collection DOAJ
description <p>In the Americas, hantaviruses cause severe cardiopulmonary syndrome (HCPS) with a high fatality rate. Hantavirus infection is commonly diagnosed using serologic techniques and reverse transcription-polymerase chain reaction. This paper presents a novel plaque reduction neutralisation test (PRNT) for detecting antibodies to Brazilian hantavirus. Using PRNT, plaque detection was enhanced by adding 0.6% of dimethyl sulfoxide into the overlay culture medium of the infected cells. This procedure facilitated clear visualisation of small plaques under the microscope and provided for easy and accurate plaque counting. The sera from 37 HCPS patients from the city of Ribeirão Preto, Brazil was evaluated for the Rio Mamoré virus (RIOMV) using PRNT. Six samples exhibited neutralising antibodies; these antibodies exhibited a low titre. The low level of seropositive samples may be due to fewer cross-reactions between two different hantavirus species; the patients were likely infected by Araraquara virus (a virus that has not been isolated) and RIOMV was used for the test. This assay offers a new approach to evaluating and measuring neutralising antibodies produced during hantavirus infections and it can be adapted to other hantaviruses, including viruses that will be isolated in the future.</p>
first_indexed 2024-03-12T18:13:51Z
format Article
id doaj.art-0276e17e6efb4ad49afd21c7adbe2641
institution Directory Open Access Journal
issn 1678-8060
language English
last_indexed 2024-03-12T18:13:51Z
publishDate 2015-08-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-0276e17e6efb4ad49afd21c7adbe26412023-08-02T09:12:44ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz1678-80602015-08-01110562462810.1590/0074-02760150102S0074-02762015000500624Development of a novel plaque reduction neutralisation test for hantavirus infectionMichelly de PáduaWilliam Marciel de SouzaFlávio LaurettiLuiz Tadeu Moraes Figueiredo<p>In the Americas, hantaviruses cause severe cardiopulmonary syndrome (HCPS) with a high fatality rate. Hantavirus infection is commonly diagnosed using serologic techniques and reverse transcription-polymerase chain reaction. This paper presents a novel plaque reduction neutralisation test (PRNT) for detecting antibodies to Brazilian hantavirus. Using PRNT, plaque detection was enhanced by adding 0.6% of dimethyl sulfoxide into the overlay culture medium of the infected cells. This procedure facilitated clear visualisation of small plaques under the microscope and provided for easy and accurate plaque counting. The sera from 37 HCPS patients from the city of Ribeirão Preto, Brazil was evaluated for the Rio Mamoré virus (RIOMV) using PRNT. Six samples exhibited neutralising antibodies; these antibodies exhibited a low titre. The low level of seropositive samples may be due to fewer cross-reactions between two different hantavirus species; the patients were likely infected by Araraquara virus (a virus that has not been isolated) and RIOMV was used for the test. This assay offers a new approach to evaluating and measuring neutralising antibodies produced during hantavirus infections and it can be adapted to other hantaviruses, including viruses that will be isolated in the future.</p>http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762015000500624&lng=en&tlng=enhantavirusplaque reduction neutralisation testcross-reaction in neutralisation testRio Mamoré virus
spellingShingle Michelly de Pádua
William Marciel de Souza
Flávio Lauretti
Luiz Tadeu Moraes Figueiredo
Development of a novel plaque reduction neutralisation test for hantavirus infection
Memorias do Instituto Oswaldo Cruz
hantavirus
plaque reduction neutralisation test
cross-reaction in neutralisation test
Rio Mamoré virus
title Development of a novel plaque reduction neutralisation test for hantavirus infection
title_full Development of a novel plaque reduction neutralisation test for hantavirus infection
title_fullStr Development of a novel plaque reduction neutralisation test for hantavirus infection
title_full_unstemmed Development of a novel plaque reduction neutralisation test for hantavirus infection
title_short Development of a novel plaque reduction neutralisation test for hantavirus infection
title_sort development of a novel plaque reduction neutralisation test for hantavirus infection
topic hantavirus
plaque reduction neutralisation test
cross-reaction in neutralisation test
Rio Mamoré virus
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762015000500624&lng=en&tlng=en
work_keys_str_mv AT michellydepadua developmentofanovelplaquereductionneutralisationtestforhantavirusinfection
AT williammarcieldesouza developmentofanovelplaquereductionneutralisationtestforhantavirusinfection
AT flaviolauretti developmentofanovelplaquereductionneutralisationtestforhantavirusinfection
AT luiztadeumoraesfigueiredo developmentofanovelplaquereductionneutralisationtestforhantavirusinfection